SEVLAREN-400 10

About

Sevlaren-400 contains sevelamer, a non-calcium, non-aluminum phosphate binder specifically formulated to manage elevated serum phosphorus levels in individuals with chronic kidney disease (CKD) who are undergoing dialysis. In the context of compromised kidney function, the body struggles to excreting excess phosphate, leading to hyperphosphatemia. This condition is a significant concern as it contributes to the development of secondary hyperparathyroidism, bone disorders (renal osteodystrophy), and an increased risk of cardiovascular complications. Sevelamer acts locally within the gastrointestinal tract, binding to dietary phosphate and preventing its absorption into the bloodstream, facilitating its elimination via feces.

The therapeutic objective of Sevlaren-400 is to effectively lower and maintain serum phosphate within target ranges, thereby mitigating the adverse effects of hyperphosphatemia. Its non-calcium nature is particularly advantageous for patients who are at risk of hypercalcemia or those already receiving calcium supplements. Consistent administration with meals is critical for maximizing its phosphate-binding capacity and achieving optimal control of phosphate balance, which is a cornerstone of comprehensive CKD management.

Uses

• Control of serum phosphorus in adult patients with CKD on dialysis.
• Prevention of hyperphosphatemia-related complications.
• Management of secondary hyperparathyroidism in CKD.
• Reduction of cardiovascular risk associated with high phosphate.

Directions For Use

Take the prescribed number of tablets with meals, as directed by your nephrologist. Do not crush or chew the tablets.

Benefits

• Effectively lowers serum phosphate levels.
• Reduces the risk of renal osteodystrophy.
• Does not contribute to systemic calcium load.
• Helps prevent vascular calcification.
• Improves overall bone health in CKD patients.
• Supports better management of chronic kidney disease.

Side Effects

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain
• Indigestion
• Flatulence
• Dyspepsia
• Headache
• Pruritus (itching)
• Peritonitis (in dialysis patients, rare)
• Bowel obstruction (rare)

Safety Measures

• Alcohol - No direct interaction, but alcohol can worsen overall health in CKD patients; moderation is advised.
• Pregnancy - Consult a doctor; use only if clearly needed and potential benefits outweigh risks.
• Breastfeeding - Consult a doctor; it is unknown if sevelamer is excreted in human milk.
• Liver - Generally safe for use in patients with liver conditions, as it is not systemically absorbed.
• Kidney - Specifically indicated for patients with chronic kidney disease on dialysis; close monitoring by a nephrologist is essential.
• Lung - No specific contraindications related to lung conditions; generally considered safe.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.